Myron M Levine

This inventor holds 21 USPTO granted patents and 1 published patent application and 3 EPO patents, primarily in Vaccine Development. Top assignees: University System of Maryland, Becton Dickinson and Company Limited, Swiss Serum and Vaccine Institute Berne. Active years: 1990-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Myron M Levine. Retrieved from https://idiyas.com/inventor/myron-m-levine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 146(Granted Patents)

Company Filing History:

19 out of 2,029

University System of Maryland

patents

2 out of 5,413

Becton Dickinson and Company Limited

patents

1 out of 5

Swiss Serum and Vaccine Institute Berne

patents

4. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2023

Loading Chart...

Areas of Expertise:

Oral Fluid Collection

Seroprotection Testing

Bacterial Conjugate Vaccines

Enterotoxigenic Vaccine

Salmonella Antigens

Vibrio Cholerae

Shigella Vaccines

DNA Probes

ETEC-CS4 Pili

Antibodies

Genetic Characterization

Vaccine Composition

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11846633 - Devices and techniques for oral fluid collection and seroprotection testing (2023-12-19),

2. 11471520 - Enhanced-enterotoxigenicmulti-valent vaccine (2022-10-18),

3. 10716839 - Compositions and methods for producing bacterial conjugate vaccines (2020-07-21),

4. 10520498 - Devices and techniques for oral fluid collection and seroprotection testing (2019-12-31),

5. 9050283 - [object Object] (2015-06-09),

6. 9011871 - [object Object] (2015-04-21),

7. 8475810 - [object Object] (2013-07-02),

8. 8137930 - [object Object] (2012-03-20),

9. 7399474 - [object Object] (2008-07-15),

10. 6902736 - Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same (2005-06-07),

11. 6190669 - Attenuated mutants of salmonella which constitutively express the Vi antigen (2001-02-20),

12. 5882653 - Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup (1999-03-16),

13. 5783196 - Gua mutants of shigella spp. and vaccines containing the same (1998-07-21),

14. 5686580 - Antibodies having binding specificity to ShET2, an enterotoxin of (1997-11-11),

15. 5628994 - Vibrio cholerae strain CVD103Hg.sup.r, method of making same, and (1997-05-13),

Title: The Legacy of Myron M Levine, Inventor from Columbia, MD

Introduction: Myron M Levine, a distinguished inventor hailing from Columbia, MD, has made significant contributions to the field of innovation through his groundbreaking work in various patents.

Latest Patents: Myron M Levine's latest patents showcase his ingenuity and forward-thinking approach to problem-solving in areas such as biotechnology, healthcare, and environmental sustainability.

Career Highlights: With a career spanning several decades, Myron M Levine has established himself as a pioneer in the world of inventions, with numerous patents to his name that have revolutionized their respective industries.

Collaborations: Throughout his career, Myron M Levine has collaborated with leading researchers, scientists, and industry experts to bring his innovative ideas to life, resulting in successful patents that have had a lasting impact.

Conclusion: Myron M Levine's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, leaving a lasting legacy in the world of patents and inventions.

Profile summary based on public USPTO records.